T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Diamondback Energy
FANG
$56.2B
| $1.42B | 0.16% |
8,208,216
+76,510
| +0.9% | +$14.7M |
|
127
Tradeweb Markets
TW
$21.9B
| $1.37B | 0.16% |
11,103,998
-820,530
| -7% | -$93M |
|
128
Alibaba
BABA
$300B
| $1.36B | 0.16% |
12,798,908
+4,174,901
| +48% | +$342M |
|
129
Molina Healthcare
MOH
$10.8B
| $1.36B | 0.16% |
3,939,288
-75,466
| -2% | -$24.9M |
|
130
Regeneron Pharmaceuticals
REGN
$82.2B
| $1.34B | 0.15% |
1,275,303
+342,429
| +37% | +$381M |
|
131
Xcel Energy
XEL
$49.1B
| $1.34B | 0.15% |
20,473,532
+7,685,638
| +60% | +$456M |
|
132
Oracle
ORCL
$442B
| $1.34B | 0.15% |
7,841,137
+2,773,479
| +55% | +$402M |
|
133
Mondelez International
MDLZ
$79.4B
| $1.33B | 0.15% |
18,015,870
+2,047,441
| +13% | +$144M |
|
134
Saia
SAIA
$9.73B
| $1.32B | 0.15% |
3,021,437
+407,158
| +16% | +$172M |
|
135
Howmet Aerospace
HWM
$112B
| $1.32B | 0.15% |
13,132,965
-617,865
| -4% | -$55.8M |
|
136
American International
AIG
$39.8B
| $1.32B | 0.15% |
17,977,306
-1,884,616
| -9% | -$140M |
|
137
Freeport-McMoran
FCX
$96.9B
| $1.31B | 0.15% |
26,150,360
-5,908,749
| -18% | -$266M |
|
138
Atlassian
TEAM
$39.4B
| $1.3B | 0.15% |
8,192,520
-1,075,582
| -12% | -$177M |
|
139
Equifax
EFX
$21.2B
| $1.28B | 0.15% |
4,348,129
+1,682,311
| +63% | +$474M |
|
140
Morgan Stanley
MS
$342B
| $1.27B | 0.15% |
12,222,263
-410,541
| -3% | -$41.3M |
|
141
Williams Companies
WMB
$90.1B
| $1.26B | 0.14% |
27,518,601
+3,527,872
| +15% | +$155M |
|
142
Prologis
PLD
$134B
| $1.25B | 0.14% |
9,927,681
-2,096,981
| -17% | -$260M |
|
143
Tenet Healthcare
THC
$21.5B
| $1.24B | 0.14% |
7,468,372
-552,140
| -7% | -$83.5M |
|
144
S&P Global
SPGI
$121B
| $1.24B | 0.14% |
2,392,390
+93,840
| +4% | +$46.4M |
|
145
Monolithic Power Systems
MPWR
$70B
| $1.21B | 0.14% |
1,313,906
-344,580
| -21% | -$297M |
|
146
Atmos Energy
ATO
$28.7B
| $1.21B | 0.14% |
8,740,559
+4,702,039
| +116% | +$604M |
|
|
EXE
147
Expand Energy Corp
EXE
$22.3B
| $1.17B | 0.13% |
14,203,038
+4,164,935
| +41% | +$318M |
|
148
Honeywell
HON
$74.6B
| $1.16B | 0.13% |
5,931,153
-5,132,584
| -46% | -$995M |
|
149
Wabtec
WAB
$49.9B
| $1.15B | 0.13% |
6,335,258
-2,074,851
| -25% | -$340M |
|
|
NVO
150
Novo Nordisk
NVO
$203B
| $1.14B | 0.13% |
9,583,435
+79,671
| +0.8% | +$10.6M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.